EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Diagnostic Value of 18F-FDG PET/CT Parameters Combined with Serum FOXM1 for Lymph Node Metastasis in Colorectal Cancer

Yuanqing Zhu, Lei Bo, Lin Li, Yinggang Sun, Bo Wu iD

Clinical Interventions in Aging · 2025

DOI: 10.2147/cia.s538944 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Interventions in Aging, 2025. Verfasst von Yuanqing Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, People's Republic of China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Radiopharmaceuticals, Lymphatic Metastasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the diagnostic value of maximum standardized uptake value (SUVmax), total lesion glycolysis (TLG), and metabolic tumor volume (MTV) in 18F-FDG PET/CT combined with serum forkhead box protein M1 (FOXM1) for detecting lymph node metastasis (LNM) in colorectal cancer (CRC).

Methods

A retrospective study was conducted on 107 CRC patients who underwent 18F-FDG PET/CT and serum FOXM1 testing, with postoperative pathology as the reference standard. Patients were divided into LNM-positive (n=52) and LNM-negative (n=55) groups. PET/CT metabolic parameters (SUVmax, TLG, MTV) and serum FOXM1 levels were compared, correlations were analyzed by Spearman's test, and receiver operating characteristic (ROC) curves were plotted to assess diagnostic efficacy.

Results

SUVmax was significantly higher in LNM-negative patients, whereas TLG, MTV, and serum FOXM1 were higher in LNM-positive patients (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18RadiopharmaceuticalsLymphatic MetastasisColorectal NeoplasmsForkhead Box Protein M1Retrospective StudiesHumansMaleFemaleMiddle AgedAgedAged, 80 and overPredictive Value of TestsLymph NodesArea Under CurveTumor BurdenSensitivity and SpecificityStatistics, NonparametricGlycolysisReproducibility of Results

Stichwörter der Autor:innen

18F-FDG PET/CTMTVSUVmaxTLGcolorectal cancerlymph node metastasisserum FOXM1

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsFOXM1 protein, humanForkhead Box Protein M1

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, People's Republic of China.
  • Department of Clinical Laboratory, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, People's Republic of China.

ORCID-Profile: Bo Wu

Zitieren

APA

Zhu, Y., Bo, L., Li, L., Sun, Y., & Wu, B. (2025). Diagnostic Value of 18F-FDG PET/CT Parameters Combined with Serum FOXM1 for Lymph Node Metastasis in Colorectal Cancer. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s538944

Vancouver

Zhu Y, Bo L, Li L, Sun Y, Wu B. Diagnostic Value of 18F-FDG PET/CT Parameters Combined with Serum FOXM1 for Lymph Node Metastasis in Colorectal Cancer. Clinical Interventions in Aging. 2025. doi:10.2147/cia.s538944

BibTeX
@article{Zhu2025,
  author = {Zhu, Yuanqing and Bo, Lei and Li, Lin and Sun, Yinggang and Wu, Bo},
  title = {Diagnostic Value of 18F-FDG PET/CT Parameters Combined with Serum FOXM1 for Lymph Node Metastasis in Colorectal Cancer},
  journal = {Clinical Interventions in Aging},
  year = {2025},
  doi = {10.2147/cia.s538944}
}
Kostenlos starten →